196 related articles for article (PubMed ID: 33613694)
1. The association of comorbidities with administration of adjuvant chemotherapy in stage III colon cancer patients: a systematic review and meta-analysis.
Boakye D; Nagrini R; Ahrens W; Haug U; Günther K
Ther Adv Med Oncol; 2021; 13():1758835920986520. PubMed ID: 33613694
[TBL] [Abstract][Full Text] [Related]
2. The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients.
Hsieh MC; Thompson T; Wu XC; Styles T; O'Flarity MB; Morris CR; Chen VW
Cancer Med; 2016 May; 5(5):871-80. PubMed ID: 26773804
[TBL] [Abstract][Full Text] [Related]
3. Associations between comorbidities and advanced stage diagnosis of lung, breast, colorectal, and prostate cancer: A systematic review and meta-analysis.
Boakye D; Günther K; Niedermaier T; Haug U; Ahrens W; Nagrani R
Cancer Epidemiol; 2021 Dec; 75():102054. PubMed ID: 34773768
[TBL] [Abstract][Full Text] [Related]
4. Treatment selection bias for chemotherapy persists in colorectal cancer patient cohort studies even in comprehensive propensity score analyses.
Boakye D; Walter V; Martens UM; Chang-Claude J; Hoffmeister M; Jansen L; Brenner H
Clin Epidemiol; 2019; 11():821-832. PubMed ID: 31564986
[TBL] [Abstract][Full Text] [Related]
5. Association Between Adjuvant Chemotherapy Duration and Survival Among Patients With Stage II and III Colon Cancer: A Systematic Review and Meta-analysis.
Boyne DJ; Cuthbert CA; O'Sullivan DE; Sajobi TT; Hilsden RJ; Friedenreich CM; Cheung WY; Brenner DR
JAMA Netw Open; 2019 May; 2(5):e194154. PubMed ID: 31099875
[TBL] [Abstract][Full Text] [Related]
6. Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study.
Minicozzi P; Vicentini M; Innos K; Castro C; Guevara M; Stracci F; Carmona-Garcia M; Rodriguez-Barranco M; Vanschoenbeek K; Rapiti E; Katalinic A; Marcos-Gragera R; Van Eycken L; Sánchez MJ; Bielska-Lasota M; Rossi PG; Sant M;
Eur J Surg Oncol; 2020 Jun; 46(6):1151-1159. PubMed ID: 32147427
[TBL] [Abstract][Full Text] [Related]
7. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
[TBL] [Abstract][Full Text] [Related]
8. Determinants of Variation in the Use of Adjuvant Chemotherapy for Stage III Colon Cancer in England.
Boyle JM; Kuryba A; Cowling TE; Aggarwal A; Hill J; van der Meulen J; Walker K; Braun MS
Clin Oncol (R Coll Radiol); 2020 May; 32(5):e135-e144. PubMed ID: 31926818
[TBL] [Abstract][Full Text] [Related]
9. Decreasing Use of Chemotherapy in Older Patients With Stage III Colon Cancer Irrespective of Comorbidities.
Walter V; Boakye D; Weberpals J; Jansen L; Haefeli WE; Martens UM; Knebel P; Chang-Claude J; Hoffmeister M; Brenner H
J Natl Compr Canc Netw; 2019 Sep; 17(9):1089-1099. PubMed ID: 31487678
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Chemotherapy for Stage II and III Colon Cancer Following Complete Resection: A Cancer Care Ontario Systematic Review.
Meyers BM; Cosby R; Quereshy F; Jonker D
Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):459-465. PubMed ID: 28341242
[TBL] [Abstract][Full Text] [Related]
11. Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature.
Böckelman C; Engelmann BE; Kaprio T; Hansen TF; Glimelius B
Acta Oncol; 2015 Jan; 54(1):5-16. PubMed ID: 25430983
[TBL] [Abstract][Full Text] [Related]
12. The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer.
Gross CP; McAvay GJ; Guo Z; Tinetti ME
Cancer; 2007 Jun; 109(12):2410-9. PubMed ID: 17510973
[TBL] [Abstract][Full Text] [Related]
13. Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study.
Baretti M; Rimassa L; Personeni N; Giordano L; Tronconi MC; Pressiani T; Bozzarelli S; Santoro A
Clin Colorectal Cancer; 2018 Sep; 17(3):e489-e498. PubMed ID: 29650416
[TBL] [Abstract][Full Text] [Related]
14. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.
Hershman D; Hall MJ; Wang X; Jacobson JS; McBride R; Grann VR; Neugut AI
Cancer; 2006 Dec; 107(11):2581-8. PubMed ID: 17078055
[TBL] [Abstract][Full Text] [Related]
15. Administration of adjuvant chemotherapy in older patients with Stage III colon cancer: an observational study.
van den Broek CBM; Puylaert CCEM; Breugom AJ; Bastiaannet E; de Craen AJM; van de Velde CJH; Liefers GJ; Portielje JEA
Colorectal Dis; 2017 Oct; 19(10):O358-O364. PubMed ID: 28873267
[TBL] [Abstract][Full Text] [Related]
16. Practice Variation in the Adjuvant Treatment of Colon Cancer in the Netherlands: A Population-based Study.
Keikes L; Koopman M; Lemmens VEPP; VAN Oijen MGH; Punt CJA
Anticancer Res; 2020 Aug; 40(8):4331-4341. PubMed ID: 32727761
[TBL] [Abstract][Full Text] [Related]
17. Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada.
Lima IS; Yasui Y; Scarfe A; Winget M
Cancer; 2011 Aug; 117(16):3833-40. PubMed ID: 21319156
[TBL] [Abstract][Full Text] [Related]
18. Influence of comorbidity on chemotherapy use for early breast cancer: systematic review and meta-analysis.
Edwards MJ; Campbell ID; Lawrenson RA; Kuper-Hommel MJ
Breast Cancer Res Treat; 2017 Aug; 165(1):17-39. PubMed ID: 28528451
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for stage III colon cancer in patients 80 years of age and older.
Badic B; Oguer M; Cariou M; Kermarrec T; Bouzeloc S; Nousbaum JB; Robaszkiewicz M; Queneherve L
Int J Colorectal Dis; 2021 Apr; 36(4):811-819. PubMed ID: 33528749
[TBL] [Abstract][Full Text] [Related]
20. Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer.
Sarasqueta C; Perales A; Escobar A; Baré M; Redondo M; Fernández de Larrea N; Briones E; Piera JM; Zunzunegui MV; Quintana JM;
BMC Cancer; 2019 Jul; 19(1):735. PubMed ID: 31345187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
